SP-624

SP-624 · Sirtsei Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SP-624, covering 2025-06-12 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder [Phase 2]